-
Orange, USAID announce mHealth initiative for Africa
Telecom services provider Orange announced its mobile health (mHealth) development initiative with the U.S. Agency for International Development (USAID) – targeting Africa.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
How Selfies Could Detect a Common Deadly Disease
People might take selfies someday to detect a deadly yet treatable medical condition, according to an award-winning team of medical inventors.
- Categories
- Health Care, Technology
-
We can’t hope to solve global ills without action against poverty
Poverty is still one of the driving forces behind ill health, a lack of access to healthcare and medicines and consistent underdevelopment.
- Categories
- Health Care
-
Telemedicine Africa Rolls Out Virtual eHealth Centers in South Africa
Telemedicine Africa has collaborated with Dimension Data and the IDC to set up private telehealth centres in South Africa.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Coming Global Boom in Private Healthcare
To many Americans, whose multi-trillion dollar government has just executed a hostile takeover of the healthcare industry, the future of care looks like lawyer-laden socialized medicine in General Motors GM -1.68%-style hospital factories.
- Categories
- Health Care
-
A Magic Wand for Nutrition and Incomes in Mozambique?
Smallholder farmers in Mozambique are growing nutritious and lucrative varieties of orange-fleshed sweet potato.
- Categories
- Agriculture, Health Care
- Region
- Sub-Saharan Africa
-
Unilever Helps Lead Coalition to Solve the Global Sanitation Crisis
2.5 billion in the world have inadequate sanitation. For businesses, that’s 2.5 billion opportunities to increase sales of infrastructure, plumbing, hygiene and cleaning products. Unilever has recognized the magnitude of the global sanitation crisis, the potential for solving it and helped lead the formation of the Toilet Board Coalition (TBC) to do their part.
- Categories
- Health Care
-
Merck’s $9.5 Billion Cubist Deal is Really About the Global War on Drug-Resistant Bacteria
Merck & Co. is paying $8.4 billion in cash and assume $1.1 billion in net debt to acquire Cubist Pharmaceuticals Inc. and join the fight against drug-resistant bacteria — a growing global threat that's slowly fueling a lucrative pharma business.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.